Policy & Regulation
Avacta Inks SARS-CoV-2 Rapid Antigen Test Clinical Collaboration
7 August 2020 - - UK-based biotherapeutics and reagents developer Avacta Group plc (AIM: AVCT) has entered into a collaboration with the Liverpool School of Tropical Medicine to clinically validate th...
ViiV Healthcare Wins FDA Nod of Expanded Dovato Indication
7 August 2020 - - The US Food and Drug Administration approved Dovato (dolutegravir/lamivudine) as a complete regimen for the treatment of HIV-1 infection to replace the current antiretroviral regimen...
Seattle Genetics Achieves Milestone Payment Under Antibody-Drug Conjugate Collaboration with GlaxoSmithKline Triggered by Blenrep FDA Approval
7 August 2020 - - The US Food and Drug Administration has approved GlaxoSmithKline's (LSE: GSK) Blenrep (belantamab mafodotin-blmf), an antibody-drug conjugate targeting B-cell maturation antigen...
Levo Therapeutics Releases Disappointing Top-line Results from Phase 3 CARE-PWS Study of LV-101 (Intranasal Carbetocin) for the Treatment of Prader-Willi Syndrome
7 August 2020 - - US-based biotechnology company Levo Therapeutics, Inc has released top-line results from the Phase 3 CARE-PWS clinical study evaluating LV-101 (intranasal carbetocin) for the treatme...
CANbridge Pharmaceuticals Receives Taiwan Marketing Approval for Nerlynx
7 August 2020 - - China-based biopharmaceutical company CANbridge Pharmaceuticals Inc has received marketing approval from the Taiwan Food and Drug Administration for Nerlynx (neratinib) for the exten...
JanOne partners with CATO SMS to explore JAN101's potential to treat COVID-19 vascular complications
7 August 2020 - Drug developer JanOne Inc (Nasdaq:JAN) said on Thursday that it has entered into an agreement with CATO SMS, a contract research organization (CRO), to help expand JanOne's curren...
Related Headlines

More Than 13% of Northwell Health Care Providers Test Positive for Antibodies

CTI BioPharma reports six months ended 30 June 2020 financial results

Caprion-HistoGeneX partners with Viroclinics-DDL to advance infectious disease research and COVID-19 therapeutic development

First Patient Enrolled in the Phase 2 Portion of the LIO-1 Trial Evaluating the Combination of Lucitanib and Opdivo in Gynecologic Cancers

PreveCeutical to begin clinical trials of cannabinoid Sol-Gel under the COVID-19 programme

Celularity awarded USD750,000 CIRM grant to advance COVID-19 treatment in California

Johnson & Johnson to supply 100m doses of investigational COVID-19 vaccine to the US Government

Relief Therapeutics Holdings AG announces Investigational New Drug permission to test inhaled RLF-100 in patients with moderate and severe COVID-19

IMV Receives Canadian Government Funding for COVID-19 Vaccine Phase 1 Clinical Study

FDA Grants Inhaled Use IND for RLF-100 to Treat Patients with Moderate and Severe COVID-19 Aiming to Prevent Progression to Respiratory Failure

NeuroRx and Relief Therapeutics Holdings receive Investigational New Drug approval to test RLF-100

ViaCyte signs contract with W L Gore & Associates

The National Institutes of Health's National Institute of Allergy and Infectious Diseases awards contract to SRI International

Alnylam Submits CTA Application for ALN-HSD, an Investigational RNAi Therapeutic for the Treatment of Nonalcoholic Steatohepatitis

US Food and Drug Administration Fast Track Designation for delgocitinib Cream for the Treatment of Adults with Moderate-to-Severe Chronic Hand Eczema